<SEC-DOCUMENT>0001193125-23-029269-index.html : 20230209
<SEC-HEADER>0001193125-23-029269.hdr.sgml : 20230209
<ACCEPTANCE-DATETIME>20230209082319
ACCESSION NUMBER:		0001193125-23-029269
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20230209
DATE AS OF CHANGE:		20230209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vanda Pharmaceuticals Inc.
		CENTRAL INDEX KEY:			0001347178
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				030491827
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-269654
		FILM NUMBER:		23601230

	BUSINESS ADDRESS:	
		STREET 1:		2200 PENNSYLVANIA AVE NW
		STREET 2:		SUITE 300E
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20037
		BUSINESS PHONE:		202-734-3400

	MAIL ADDRESS:	
		STREET 1:		2200 PENNSYLVANIA AVE NW
		STREET 2:		SUITE 300E
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20037
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>d439520ds3.htm
<DESCRIPTION>S-3
<TEXT>
Document 1 - file: d439520ds3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>d439520dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
Document 2 - file: d439520dex42.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d439520dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 3 - file: d439520dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>d439520dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
Document 4 - file: d439520dex232.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>d439520dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 5 - file: d439520dexfilingfees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g439520g0208014757712.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g439520g0208014757712.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g439520g03p03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 7 - file: g439520g03p03.jpg

</DOCUMENT>
</SEC-DOCUMENT>